FOX RUN MANAGEMENT, L.L.C.
Position in RGC — Regencell Bioscience Holdings Ltd
CIK 1533457
GREENWICH, CT
Position in RGC
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$126,008
New position
Shares Held
20,691
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#11
of 35 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $6,581,949 across 12 Drug Manufacturers - Specialty & Generic names. RGC ranks #12 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
29,511 | $2,120,660 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,876 | $1,020,662 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
44,817 | $804,913 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
139,728 | $688,859 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
18,952 | $466,408 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
14,556 | $293,740 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
63,112 | $283,372 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
16,028 | $277,444 |
All Filings in RGC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,008 | 20,691 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||